Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Soleo Health is an active U.S.-based independent company founded in 2014 specializing in complex specialty pharmacy services including home-based infusion therapy across multiple therapeutic areas focusing on rare/orphan diseases and chronic conditions requiring specialized medication management. It operates nationally with extensive accreditations and licenses covering all states plus over thirty infusion centers nationwide. The company collaborates closely with pharmaceutical manufacturers such as Genentech/Roche providing limited distribution access to critical biologic therapies while leveraging its proprietary real-world evidence platform SoleMetrics® to optimize patient outcomes reporting that supports payors/providers/pharma stakeholders alike. Recently acquired by two healthcare-focused private equity firms in early 2025 it continues expanding its footprint under experienced leadership committed to simplifying complex care delivery through personalized patient-centric approaches supported by interdisciplinary teams of clinicians.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Soleo Health.